
1. antimicrob agents chemother. 2016 dec 27;61(1). pii: e01949-16. doi:
10.1128/aac.01949-16. print 2017 jan.

altered plasmodium falciparum sensitivity antiretroviral protease
inhibitor lopinavir associated polymorphisms pfmdr1.

sonoiki e(1), nsanzabana c(1), legac j(1), sindhe km(1), derisi j(2), rosenthal
pj(3).

author information: 
(1)department medicine, university california, san francisco, california,
usa.
(2)howard hughes medical institute department biochemistry and
biophysics, university california, san francisco, california, usa.
(3)department medicine, university california, san francisco, california,
usa philip.rosenthal@ucsf.edu.

the hiv protease inhibitor lopinavir inhibits plasmodium falciparum aspartic
proteases (plasmepsins) parasite development, children receiving
lopinavir-ritonavir experienced fewer episodes malaria receiving
other antiretroviral regimens. resistance lopinavir selected vitro over
∼9 months, ∼4-fold decreased sensitivity. whole-genome sequencing of
resistant parasites showed mutation increased copy number pfmdr1 a
mutation protein unknown function, polymorphisms plasmepsin
genes.

copyright © 2016 american society microbiology.

doi: 10.1128/aac.01949-16 
pmcid: pmc5192118
pmid: 27821443  [indexed medline]

